RESEARCH ARTICLE Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific FrancËoise Mathieu-DaudeÂ1,2*, Aurore Claverie3,4, Catherine Plichart3, Denis Boulanger2, Fingani A. Mphande1, Herve C. Bossin4* a1111111111 1 UMR MIVEGEC, IRD, CNRS, UM, Institut de Recherche pour le DeÂveloppement, NoumeÂa, Nouvelle- CaleÂdonie, 2 UMR MIVEGEC IRD, CNRS, UM, Institut de Recherche pour le DeÂveloppement, Montpellier, a1111111111 France, 3 PoÃle de recherche et de veille sur les maladies infectieuses eÂmergentes, Institut Louis MalardeÂ, a1111111111 Papeete, Tahiti, PolyneÂsie francËaise, 4 Laboratoire d'entomologie meÂdicale, Institut Louis MalardeÂ, Paea, a1111111111 Tahiti, PolyneÂsie francËaise a1111111111 *
[email protected] (FMD);
[email protected] (HCB) Abstract OPEN ACCESS Citation: Mathieu-Daude F, Claverie A, Plichart C, Boulanger D, Mphande FA, Bossin HC (2018) Background Specific human antibody responses to Aedes Aedes mosquitoes severely affect the health and wellbeing of human populations by trans- aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to mitting infectious diseases. In French Polynesia, Aedes aegypti is the main vector of den- disease vectors in the Pacific. PLoS Negl Trop Dis gue, chikungunya and Zika, and Aedes polynesiensis the primary vector of Bancroftian 12(7): e0006660. https://doi.org/10.1371/journal. filariasis and a secondary vector of arboviruses. Tools for assessing the risk of disease pntd.0006660 transmission or for measuring the efficacy of vector control programmes are scarce. A Editor: Charles Apperson, North Carolina State promising approach to quantify the human-vector contact relies on the detection and the University, UNITED STATES quantification of antibodies directed against mosquito salivary proteins.